KZIA

Kazia Therapeuti

• Reuters·6d ago

  Kazia Therapeutics files Form 3 as David Cain named Director, CMC

• TipRanks·6d ago

  Kazia Therapeutics Announces Board Changes and AGM Outcomes as It Highlights Oncology Pipeline

• TipRanks·03/30 10:30

  Kazia Therapeutics Taps Leerink for New ATM Facility as Cash Bolstered by Late-2025 PIPE

• TipRanks·03/19 21:27

  Kazia Therapeutics Posts Wider Half-Year Loss but Bolsters Cash, Pipeline and Nasdaq Compliance

• Reuters·03/18 23:18

  Kazia Therapeutics Director Steven R. S. Coffey Files Initial Beneficial Ownership Statement

• Reuters·03/18 22:36

  Kazia Therapeutics files initial beneficial ownership statement for CEO John E. Friend II

• Reuters·03/18 22:33

  Kazia Therapeutics’ Program Director Jeremy Simpson files initial beneficial ownership statement

• Reuters·03/18 21:55

  Kazia Therapeutics Limited VP of Finance and Controller Jeffrey Bonacorda files Form 3 initial beneficial ownership statement

• Reuters·03/18 21:48

  Kazia Therapeutics files Form 3 initial beneficial ownership statement for Director Robert F Apple

• Reuters·03/18 11:18

  BRIEF-Kazia Therapeutics Ltd Files For Offering Of Up To $200 Million Of American Depositary Shares Representing Ordinary Shares Or Warrants - SEC Filing

• Reuters·03/16 04:38

  Kazia Therapeutics H1 net loss widens 20.08% to AUD 12.55 million

• Benzinga·03/04 17:05

  12 Health Care Stocks Moving In Wednesday's Intraday Session

• Reuters·02/11 06:14

  Kazia Therapeutics Limited Releases 2025 Annual Report

• Benzinga·01/30 13:05

  Kazia Therapeutics Announces Preclinical And Translational Data Supporting Development Of NDL2 To Selectively Eliminate Nuclear PD-L1

• TipRanks·01/30 13:05

  Kazia Therapeutics’ NDL2 shows anti-tumor efficacy in preclinical data